Paulson Wealth Management’s Biogen BIIB Stock Holding History

Paulson Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-204	Closed	-$65K	–	158
2017 Q4	$65K	Buy	+204	New	+$65.4K	0.06%	174

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Paulson Wealth Management's BIIB Position: Q1 2018 in Review

Paulson Wealth Management sold out of Biogen (BIIB) in Q1 2018, closing a stake of 204 shares — an estimated $65K sold.

Paulson Wealth Management first reported a position in BIIB in Q4 2017 and held it in 1 quarter. The position peaked at $65K in Q4 2017. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

Paulson Wealth Management reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
Paulson Wealth Management sold 204 Biogen shares in Q1 2018, an estimated $65K.
Paulson Wealth Management first reported a position in Biogen in Q4 2017 and held it in 1 quarter.
Paulson Wealth Management's Biogen position peaked at $65K in Q4 2017.
1,103 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Paulson Wealth Management's 13F filing for Q1 2018, filed 2 May 2018.